Clinical trial
A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial…
NCT00101439 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00101439 |
|---|---|
| Title | A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Postprandial Lipoprotein Response in Patients With Primary Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | ezetimibe, Comparator: placebo |
| Enrollment | 58 |
| Start date | Nov 10, 2005 |
| Primary completion | Oct 24, 2006 |
| Completion | Nov 8, 2006 |
| First posted | Jan 11, 2005 |
| Last update posted | Jun 18, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: